
Manifold Bio
formerly Manifold BiotechnologiesTissue-targeted medicines, designed in vivo
Cambridge, United States · Founded 2020 · $89.4M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- manifold.bio
- Total Funding
- $89.4M
- Last Round
- $22.0M Extension RoundJan 2024
- Rounds
- 4
About
Platform therapeutics company building an AI-guided in vivo drug discovery engine for tissue-targeted medicines.
Summary
Manifold Bio is a Biotech company based in Cambridge, United States, founded in 2020. It has raised $89.4M in total across 4 rounds, most recently a $22.0M Extension Round round in Jan 2024. Investors include KHK Fund, Triatomic Capital and Playground Global.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Neuralink is building a brain-computer interface for medical needs and greater human potential.

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
